Agilent highlights genomics and cell analysis solutions for cancer research at aacr 2022

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced cancer research innovations in cell analysis and genomics that will be on show at the american association for cancer research annual meeting, being held april 8 - 13, 2022 in new orleans, louisiana. “cancer research is an important focus area for agilent. the aacr conference presents an exciting opportunity to engage with customers, partners, and thought leaders in this field,” said jodi barrientos, vice
A Ratings Summary
A Quant Ranking